1. Murray, CJ, Styblo, K, Rouillon, A. Tuberculosis in developing countries: burden, intervention, and cost. Bulletin of the International Union against Tuberculosis and Lung Disease 1990; 65: 6–24.
2. Nelson, LJ, Wells, CD. Global epidemiology of childhood tuberculosis. International Journal of Tuberculosis and Lung Disease 2004; 8: 636–647.
3. Stark, J. Childhood tuberculosis: ending the neglect. International Journal of Tuberculosis and Lung Disease 2002; 6: 373–374.
4. Huebner, RE, Schein, MF, Bass, JR Jr.. The tuberculin skin test. Clinical Infectious Disease 1993; 17: 968–975.
5. Mori, T, et al. Specific detection of tuberculosis infection: an interferon-γ-based assay using new antigens. American Journal of Respiratory Critical Care Medicine 2004; 170: 59–64.
6. Brock, I, et al. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. American Journal of Respiratory Critical Care Medicine 2004; 170: 65–69.
7. Ewer, K, et al. Comparison of T-cell based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168–1173.
8. Kang, YA, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. Journal of the American Medical Association 2005; 293: 2756–2761.
9. Pai, M, et al. Mycobacterium tuberculosis infection in heath care workers in rural India. Journal of the American Medical Association 2005; 293: 2746–2755.
10. Mazurek, GH, et al. Comparison of a whole-blood interferon γ assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. Journal of the American Medical Association 2001; 286: 1740–1747.
11. Ferrara, G, et al. Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection. American Journal of Respiratory Critical Care Medicine 2005; 172: 631–635.
12. Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON®-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. Morbidity and Mortality Weekly Report 2005; 54: 49–55.
13. Dogra, S, et al. Comparison of a whole blood interferon- γ assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. Journal of Infection 2006; 20: 1–10.
14. Nakaoka, H, et al. Risk for tuberculosis among children. Emerging Infectious Diseases 2006; 12: 1383–1388.
15. Tsiouris, SJ, et al. Results of a tuberculosis-specific IFN- γ assay in children at high risk for tuberculosis infection. International Journal of Tuberculosis and Lung Disease 2006; 10: 939–941.
16. Liebeschuetz, S, et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004; 364: 2196–2203.
17. Soysal, A, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005; 366: 1443–1451.
18. Hill, PC, et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to mycobacterium tuberculosis. Pediatrics 2006; 117: 1542–1548.
19. WHO. Treatment of Tuberculosis: Guidelines for National Programmes 2nd edn.Geneva: World Health Organization, 1997, pp. 19–24.
20. National Center for Tuberculosis and Leprosy Control, Cambodia. Technical Guidelines for Tuberculosis Control in Cambodia. Ministry of Health, Kingdom of Cambodia, 2003 [in Khmer].
23. Rieder, HL. Epidemiological Basis of TB Control. Paris: International Union Against Tuberculosis and Lung Disease; 1999, pp. 26–43.
24. Wang, L, et al. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804–809.
25. Lockman, S, et al. Tuberculin reactivity in a pediatric population with high BCG vaccination coverage. International Journal of Tuberculosis and Lung Disease 1999; 3: 23–30.
26. Chadha, VK, Jagannatha, PS, Kumar, P. Can BCG-vaccinated children be included in tuberculin surveys to estimate the annual risk of tuberculosis infection in India? International Journal of Tuberculosis and Lung Disease 2004; 8: 1437–1442.
27. Rothel, JS, Andersen, P. Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Review of Anti-infective Therapy 2005; 3: 981–993.
28. National Center for Tuberculosis and Leprosy Control, Cambodia. Report on National Tuberculosis Prevalence Survey 2002. Ministry of Health, Kingdom of Cambodia, 2005.
29. Von Reyn, CF, et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United State. International Journal of Tuberculosis and Lung Disease 2001; 5: 1122–1128.
30. Centers for Disease Control and Prevention. Guidelines for the investigation of contacts of persons with infectious tuberculosis. Morbidity and Mortality Weekly Report 2005; 54: 1–47.
31. Orme, IM, Collins, FM. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cellular Immunology 1984; 84: 113–120.
32. National Center for Tuberculosis and Leprosy Control, Cambodia.National HIV sero-prevalence survey amongst TB patients in Cambodia, 2005. Ministry of Health, Kingdom of Cambodia, 2006.
33. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Morbidity and Mortality Weekly Report 2000; 49: 1–51.